Products & Services · Total revenues
Net revenues from collaborations — Total revenues
Alnylam Pharmaceuticals Net revenues from collaborations — Total revenues increased by 100.5% to $82.08M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 17.3%, from $99.19M to $82.08M. Over 4 years (FY 2021 to FY 2025), Net revenues from collaborations — Total revenues shows an upward trend with a 32.2% CAGR.
Analysis
Metric ID:
alny_segment_net_revenues_from_collaborations_total_revenuesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.24M | $45.24M | $45.24M | $25.95M | $9.03M | $29.3M | $70.65M | $36.46M | $5.84M | $427.47M | $76.41M | $118.55M | $227.34M | $57.39M | $106.95M | $99.19M | $61.5M | $351.74M | $40.94M | $82.08M |
| QoQ Change | — | +0.0% | +0.0% | -42.6% | -65.2% | +224.6% | +141.1% | -48.4% | -84.0% | >999% | -82.1% | +55.2% | +91.8% | -74.8% | +86.4% | -7.3% | -38.0% | +472.0% | -88.4% | +100.5% |
| YoY Change | — | — | — | — | -80.1% | -35.2% | +56.2% | +40.5% | -35.2% | >999% | +8.2% | +225.1% | >999% | -86.6% | +40.0% | -16.3% | -72.9% | +512.9% | -61.7% | -17.3% |
Range$5.84M – $427.47M
CAGR+13.4%
Avg YoY Growth+351.7%
Median YoY Growth-4.1%
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's net revenues from collaborations — total revenues?
- Alnylam Pharmaceuticals (ALNY) reported net revenues from collaborations — total revenues of $82.08M in Q1 2026.
- How has Alnylam Pharmaceuticals's net revenues from collaborations — total revenues changed year-over-year?
- Alnylam Pharmaceuticals's net revenues from collaborations — total revenues decreased by 17.3% year-over-year, from $99.19M to $82.08M.
- What is the long-term trend for Alnylam Pharmaceuticals's net revenues from collaborations — total revenues?
- Over 4 years (2021 to 2025), Alnylam Pharmaceuticals's net revenues from collaborations — total revenues has grown at a 32.2% compound annual growth rate (CAGR), from $180.95M to $553.37M.